 Marrone Bio Innovations NASDAQ: MBII announces its next round of earnings this Monday, August 10. Here is Benzingas everything-that-matters guide for this Mondays Q2 earnings announcement.Earnings and Revenue Wall Street analysts see Marrone Bio Innovations reporting a quarterly EPS of -0.04 per share on sales of 10.38 million. In the same quarter last year, Marrone Bio Innovations posted EPS of -0.06 on sales of 7.00 million. If the company were to match the consensus estimate when it reports Monday, earnings would be up 33.33. Revenue would be up 2.67 from the same quarter last year. Heres how the companys EPS has stacked up against analyst estimates in the past:Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019 EPS Estimate -0.03 -0.06 -0.05 -0.04 EPS Actual -0.05 -0.07 -0.05 -0.06 Revenue Estimate 10.11 M 7.34 M 6.95 M 8.33 M Revenue Actual 9.65 M 6.70 M 6.97 M 7.00 M Stock Performance Over the past 52-week period, shares of Marrone Bio Innovations have declined 4.63. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release.View more earnings on MBIIDont be surprised to see the stock move on comments made during its conference call. Marrone Bio Innovations is scheduled to hold the call at 16:30:00 ET and can be accessed here: more from Benzinga Benzingas Top Upgrades, Downgrades For July 28, 2020C 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 